Wikipedia -WSS

Wikipedia

author：explore 2025-09-27 10:01:41 - browse：2

An Ozempic pen connects dots that make up the shape o a brain — coverage from STAT — ILLUSTRATION: CHRISTINE KAO/STAT; PHOTOS: ADOBE

Drugs like Ozempic and Wegovy — already game changers for diabetes and obesity — are being studied to treat an entirely different growing health problem: mental health illnesses, including depression and bipolar disorder.

Early data and anecdotes suggest that this class of GLP-1 drugs could help patients feel less depressed and anxious. The treatment may also fight the decline in cognitive and executive function that many people with mental health disorders experience, like worsening memory and losing the ability to focus and plan.

If further research yields positive results, it could drive even more demand for the highly popular GLP-1 treatments, which have increasingly been shown to help with problems across the body, such as heart and kidney complications. And especially if the cognitive benefits are proven out, the GLP-1 drugs would plug a critical gap in current treatments for depression, since most depression drugs help with mood, but close to none address cognitive symptoms that affect memory and attention.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Readout LOUD podcast: How biotech is using artificial intelligence

WSS

Doctors' information doesn't help them choose wisely when sick

Industry veterans launch new biotech VC with $310M

5 ways to address the shortage of health care workers

Gilead might be held responsible for not developing a drug

Senators start work on Medicare physician payment reform

Are embryos people? Reproductive medicine's future depends on the answer

hotspot

Wikipedia

focus

Medicare details structure of new drug price negotiation program

Biden report: The neurospychology of memory and aging

Medical records are filled with copy

Study fuels hope CAR

Cancer drug shortages should be causing more outrage

Doctor of U.S. President Joe Biden says he is fit for duty

Malaria cases in Florida and Texas: Here’s what you need to know

NEJM study measures Covid brain fog, impact on IQ

DIEP, the 'gold standard' of breast reconstruction, is under threat

Medicare Advantage isn’t working — for anyone

knowledge

What we’ve learned from the Aduhelm mess

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Redefining sustainability for the pharmaceutical industry

Doctor of U.S. President Joe Biden says he is fit for duty

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

Industry veterans launch new biotech VC with $310M

leisure time

leisure time

focus

focus